Aspargo Labs Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

Aspargo Labs General Information

Description

Aspargo Labs Inc is a commercial stage, specialty pharmaceutical and med-tech company focused on designing, developing and marketing oral liquid suspension formulations of oral solid dose Rx and OTC medications for administration in personalized, digitally connected, electronic drug delivery devices and accompanying mobile apps. Its first commercial product, Sildenafil Oral Suspension is a proprietary oral spray liquid suspension formulation of sildenafil citrate, the active ingredient in VIAGRA, indicated for the treatment of erectile dysfunction (ED).

Contact Information

Formerly Known As
Virgatech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17 State Street
  • Suite 3220
  • New York, NY 10004
  • United States
+1 (646)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 17 State Street
  • Suite 3220
  • New York, NY 10004
  • United States
+1 (646)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspargo Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 10-Jan-2025 Cancelled Generating Revenue
3. Early Stage VC 05-Dec-2022 Completed Generating Revenue
2. Early Stage VC 28-Mar-2022 $1.53M $9.4M Completed Generating Revenue
1. Seed Round 15-Oct-2020 $7.9M $7.9M Completed Generating Revenue
To view Aspargo Labs’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aspargo Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Aspargo Labs Inc is a commercial stage, specialty pharmaceutical and med-tech company focused on designing, developing a
Biotechnology
New York, NY
36 As of 2025

Darmstadt, Germany
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aspargo Labs Competitors (2)

One of Aspargo Labs’s 2 competitors is Merck, a Corporation company based in Darmstadt, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck Corporation Darmstadt, Germany
Pfizer Corporation New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

Aspargo Labs Patents

Aspargo Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12558700-B1 Pump dispenser having a safety lock pump head Active 12-Mar-2025
US-20260273561-A1 Pump dispenser having a safety lock pump head Pending 12-Mar-2025
WO-2026192600-A1 Pump dispenser having a safety lock pump head Pending 12-Mar-2025
WO-2026142738-A1 Medication cartridge Pending 23-Dec-2024
US-20260115749-A1 Pump dispenser having a safety lock cap Pending 24-Sep-2024 B05B11/1059
To view Aspargo Labs’s complete patent history, request access »

Aspargo Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspargo Labs Investments (1)

Aspargo Labs’s most recent deal was a Corporate Asset Purchase with Farmalider (International Rights to Sildenafil Spray in Madrid, Spain). The deal was made on 29-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Farmalider (International Rights to Sildenafil Spray in Madrid, Spain) 29-Sep-2020 Corporate Asset Purchase Buildings and Property
To view Aspargo Labs’s complete investments history, request access »

Aspargo Labs FAQs

  • When was Aspargo Labs founded?

    Aspargo Labs was founded in 2019.

  • Where is Aspargo Labs headquartered?

    Aspargo Labs is headquartered in New York, NY.

  • What is the size of Aspargo Labs?

    Aspargo Labs has 36 total employees.

  • What industry is Aspargo Labs in?

    Aspargo Labs’s primary industry is Biotechnology.

  • Is Aspargo Labs a private or public company?

    Aspargo Labs is a Private company.

  • What is Aspargo Labs’s current revenue?

    The current revenue for Aspargo Labs is .

  • How much funding has Aspargo Labs raised over time?

    Aspargo Labs has raised $10.4M.

  • Who are Aspargo Labs’s competitors?

    Merck and Pfizer are competitors of Aspargo Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process